H&Q LIFE SCIENCES INVESTORS
NSAR-B, EX-27, 2000-11-21
Previous: H&Q LIFE SCIENCES INVESTORS, NSAR-B, EX-23, 2000-11-21
Next: SPDR TRUST SERIES 1, N-30D, 2000-11-21



<TABLE> <S> <C>


<ARTICLE>                     6

<S>                                             <C>
<PERIOD-TYPE>                                        12-MOS
<FISCAL-YEAR-END>                               SEP-30-2000
<PERIOD-START>                                  OCT-01-1999
<PERIOD-END>                                    SEP-30-2000
<INVESTMENTS-AT-COST>                            98,804,776
<INVESTMENTS-AT-VALUE>                          317,930,009
<RECEIVABLES>                                       599,689
<ASSETS-OTHER>                                      156,552
<OTHER-ITEMS-ASSETS>                                      0
<TOTAL-ASSETS>                                  318,686,240
<PAYABLE-FOR-SECURITIES>                                  0
<SENIOR-LONG-TERM-DEBT>                                   0
<OTHER-ITEMS-LIABILITIES>                           414,885
<TOTAL-LIABILITIES>                                 414,885
<SENIOR-EQUITY>                                           0
<PAID-IN-CAPITAL-COMMON>                        104,163,767
<SHARES-COMMON-STOCK>                             8,085,152
<SHARES-COMMON-PRIOR>                             7,802,538
<ACCUMULATED-NII-CURRENT>                                 0
<OVERDISTRIBUTION-NII>                                    0
<ACCUMULATED-NET-GAINS>                           5,963,964
<OVERDISTRIBUTION-GAINS>                                  0
<ACCUM-APPREC-OR-DEPREC>                        208,143,625
<NET-ASSETS>                                    318,271,356
<DIVIDEND-INCOME>                                     6,014
<INTEREST-INCOME>                                 1,014,871
<OTHER-INCOME>                                            0
<EXPENSES-NET>                                    3,446,533
<NET-INVESTMENT-INCOME>                          (2,425,648)
<REALIZED-GAINS-CURRENT>                         22,495,993
<APPREC-INCREASE-CURRENT>                       171,484,854
<NET-CHANGE-FROM-OPS>                           191,555,199
<EQUALIZATION>                                            0
<DISTRIBUTIONS-OF-INCOME>                                 0
<DISTRIBUTIONS-OF-GAINS>                         22,222,642
<DISTRIBUTIONS-OTHER>                                     0
<NUMBER-OF-SHARES-SOLD>                                   0
<NUMBER-OF-SHARES-REDEEMED>                               0
<SHARES-REINVESTED>                                 282,614
<NET-CHANGE-IN-ASSETS>                          186,708,552
<ACCUMULATED-NII-PRIOR>                                   0
<ACCUMULATED-GAINS-PRIOR>                                 0
<OVERDISTRIB-NII-PRIOR>                                   0
<OVERDIST-NET-GAINS-PRIOR>                                0
<GROSS-ADVISORY-FEES>                             2,968,131
<INTEREST-EXPENSE>                                        0
<GROSS-EXPENSE>                                   3,446,533
<AVERAGE-NET-ASSETS>                                      0
<PER-SHARE-NAV-BEGIN>                                17,804
<PER-SHARE-NII>                                      (0.300)
<PER-SHARE-GAIN-APPREC>                              24,756
<PER-SHARE-DIVIDEND>                                      0
<PER-SHARE-DISTRIBUTIONS>                             2,895
<RETURNS-OF-CAPITAL>                                      0
<PER-SHARE-NAV-END>                                  39,365
<EXPENSE-RATIO>                                        1.51



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission